What ICD‑10 code should I assign for a patient with a Patient Health Questionnaire‑9 (PHQ‑9) score of 10 indicating moderate depression, and what first‑line treatment is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PHQ-9 Score of 10: ICD-10 Coding and First-Line Treatment

A PHQ-9 score of 10 indicates moderate depression and should be coded as F32.1 (Major depressive disorder, single episode, moderate) or F33.1 (Major depressive disorder, recurrent, moderate), depending on episode history, and first-line treatment consists of either an SSRI (such as sertraline 50 mg daily) or individually guided self-help based on cognitive behavioral therapy with behavioral activation. 1, 2, 3

Immediate Safety Assessment

  • Always assess PHQ-9 item 9 (self-harm thoughts) first, regardless of the total score of 10, as any endorsement of suicidal ideation mandates immediate emergency psychiatric evaluation even when the total score suggests only moderate depression 1, 2, 3
  • If item 9 is endorsed at any frequency, arrange one-to-one observation and remove access to lethal means while awaiting emergency psychiatric evaluation 3

ICD-10 Coding Algorithm

For a PHQ-9 score of 10:

  • Use F32.1 (Major depressive disorder, single episode, moderate) if this is the patient's first depressive episode 4, 5
  • Use F33.1 (Major depressive disorder, recurrent, moderate) if the patient has a history of prior depressive episodes 4, 5
  • A score of 10 falls within the 8-14 range, which represents moderate depressive symptomatology with mild-to-moderate functional impairment 1, 2

Diagnostic Workup Before Treatment

  • Check thyroid-stimulating hormone, complete metabolic panel, complete blood count, vitamin B12, and folate to rule out medical causes of depression 3
  • Review current medications for mood-altering side effects, particularly interferon, corticosteroids, and beta-blockers 3
  • Assess for substance-induced causes of depressive symptoms 6

First-Line Treatment Options

For PHQ-9 scores 8-14 (moderate depression), you have two evidence-based first-line options:

Option 1: Low-Intensity Psychological Intervention

  • Initiate individually guided self-help based on cognitive behavioral therapy (CBT) with behavioral activation and problem-solving components 2, 3
  • Include structured physical activity programs as part of the treatment plan 3

Option 2: Pharmacologic Treatment

  • Start an SSRI such as sertraline 50 mg daily, escitalopram 10 mg daily, or fluoxetine 20 mg daily 3
  • SSRIs are preferred over other antidepressants due to their favorable side-effect profile and extensive evidence base 3

When to Escalate Care

  • Refer to psychology or psychiatry for diagnostic confirmation when PHQ-9 scores fall in the 8-14 range, as formal diagnostic assessment is recommended to confirm the presence or absence of a mood disorder 6, 1
  • If the score progresses to ≥15 on repeat screening, immediate referral to psychology and/or psychiatry becomes mandatory for high-intensity interventions 1, 2

Monitoring and Follow-Up

  • Reassess with PHQ-9 at regular intervals during treatment (typically every 2-4 weeks initially) to monitor treatment response 3
  • Continue monitoring at 3,6, and 12 months, or during times of personal transition, family crisis, or changes in health status 1, 3

Common Pitfalls to Avoid

  • Never omit assessment of item 9, as patients can have moderate total scores but still endorse suicidal ideation requiring immediate intervention 1, 2, 3
  • Do not delay treatment while waiting for specialty referral; initiate first-line treatment (either low-intensity CBT or SSRI) while arranging consultation 2, 3
  • Avoid using the PHQ-9 algorithm scoring method for screening purposes, as it has lower sensitivity compared to the summed-item score method; the summed score at cutoff ≥10 has better diagnostic performance 7
  • In elderly patients or those with cognitive impairment, consider alternative assessment tools, as the PHQ-9 loses accuracy in these populations 2, 3

References

Guideline

Management of Mild Depressive Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Significance of PHQ-9 Score for Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Depression Management Based on PHQ-9 Scores

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The PHQ-9: validity of a brief depression severity measure.

Journal of general internal medicine, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Is the Patient Health Questionnaire (PHQ-9) supposed to be used every day?
Can I increase Cymbalta (duloxetine) from 20mg daily to 40mg daily in a patient with moderate to severe depression and a Patient Health Questionnaire-9 (PHQ9) score of 14?
How should I assess and manage a 52‑year‑old female presenting for psychiatric follow‑up after an Emergency Department overdose of sleeping pills, who has severe Major Depressive Disorder (MDD) with a Patient Health Questionnaire‑9 (PHQ‑9) score of 15, 20‑lb weight loss (Body Mass Index 17.5), insomnia, psychomotor retardation, impaired concentration, and a recent suicide attempt?
What is the standard scoring guide for assessing depression, such as the Patient Health Questionnaire-9 (PHQ-9)?
What is the management approach for a patient with a Patient Health Questionnaire-9 (PHQ-9) score of 7?
Is Tempus xT (CPT 81459) next‑generation sequencing panel and Tempus xR (CPT 81456) whole‑transcriptome RNA sequencing panel medically necessary and covered by Wisconsin Group Health for a 36‑year‑old female with stage IV intrahepatic cholangiocarcinoma (cT1b, cN1, cM1) currently receiving gemcitabine, cisplatin, and immunotherapy and being considered for a single‑arm phase 2 trial adding anti‑PD‑1 (zimberelimab) and CD73 inhibitor (quemliclustat)?
How should I write the prescription for continuous subcutaneous insulin pump infusion of insulin lispro (Humalog) 100 U/mL with a total daily dose ≤ 100 U?
What antihypertensive should be added for a 44‑year‑old with chronic kidney disease stage 3 (eGFR ≈ 32 mL/min/1.73 m²) already on lisinopril 20 mg twice daily?
Is there a cure for lymphedema?
What is the appropriate emergency assessment and management for a patient presenting with acute respiratory failure?
What laboratory tests should be ordered for a perimenopausal woman (late 30s to early 50s) presenting with irregular cycles, vasomotor symptoms, mood changes, or sleep disturbance?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.